Results 161 to 170 of about 22,001 (226)

Lupus anticoagulant as a marker of autoimmunity in recurrent pregnancy loss; a case report

open access: bronze, 1991
Juan Balasch   +3 more
openalex   +1 more source

Rare case of acquired hemophilia B with positive lupus anticoagulant: presenting with bleeding and thrombosis

open access: gold
Rahmat Cahyanur   +4 more
openalex   +1 more source

Lupus anticoagulant

Blood Reviews, 1991
Acquired antibodies to phospholipids form a heterogeneous group, which may be detected in vitro by the inhibition of phospholipid dependent tests of coagulation (lupus anticoagulant) and also by immunological assays, such that a combined approach is required for their reliable detection.
M D, Creagh, M, Greaves
openaire   +2 more sources

The lupus anticoagulant

Arthritis & Rheumatism, 1976
AbstractThe clinical and laboratory experience with the lupus anticoagulant was reviewed in 37 patients. The anticoagulant is thought to act by blocking the activation of prothrombin by the prothrombin activator complex of factors Xa, V, and phospholipid.
M, Boxer, L, Ellman, A, Carvalho
openaire   +2 more sources

Familial lupus anticoagulants

British Journal of Haematology, 1987
SummaryThree families having more than one affected member with SLE or lupus‐like disease were investigated by global coagulation tests as well as methods based on dilute thromboplastin, Russell's viper venom and thermal stability/absorption, and by RIA for anticardiolipin (CL) antibodies. Of the 19 persons, 11 had SLE or lupus‐like disease.
I J, Mackie, C B, Colaco, S J, Machin
openaire   +2 more sources

Lupus Anticoagulant Testing

2013
Antiphospholipid antibodies are a heterogenous group of autoantibodies directed against glycoproteins in concert with anionic phospholipids. In clinical laboratory practice, antiphospholipid antibody evaluations usually consist of a combination of the following: anticardiolipin antibody assay, anti-beta 2 glycoprotein I assay, and at least two lupus ...
Karen, Moffat   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy